Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:12:02 EDT Sat 27 Jul 2024
Enter Symbol
or Name
USA
CA



Q:CSTL - CASTLE BIOSCIENCES INC - http://www.castelle.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CSTL - Q0.118.94·25.070.121.06+1.759.1498.49,8825,07019.71  21.08  19.1625.91  12.0716:01:39Jul 2215 min RT 2¢

Recent Trades - Last 10 of 5070
Time ETExPriceChangeVolume
16:01:39Q21.061.7549
16:01:34Q21.061.75382
16:01:31Q21.061.751,732
16:01:28Q21.061.75133
16:01:24Q21.061.75370
16:01:21Q21.061.7561
16:01:19Q21.061.75258
16:01:17Q21.061.751,171
16:00:07Q21.061.7579
16:00:06Q21.061.751,920

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-07-22 07:00U:CSTLNews ReleaseCastle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma
2024-07-15 07:00U:CSTLNews ReleaseCastle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024
2024-07-11 07:00U:CSTLNews ReleaseCastle Biosciences Honored with Top Workplaces Awards
2024-06-24 07:00U:CSTLNews ReleaseRecent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences' TissueCypher(TM) Test
2024-06-20 07:00U:CSTLNews ReleaseCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-06-14 16:30U:CSTLNews ReleaseCastle Biosciences' Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year(TM) 2024 Gulf South Award Winner
2024-05-30 16:30U:CSTLNews ReleaseCastle Biosciences to Present New Data at 2024 ASCO(TM) Annual Meeting Highlighting Use of DecisionDx(TM)-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
2024-05-29 16:30U:CSTLNews ReleaseNew Publication Shows DecisionDx(TM)-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis
2024-05-15 07:00U:CSTLNews ReleaseCastle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
2024-05-10 07:00U:CSTLNews ReleaseCastle Biosciences' IDgenetix(TM) Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"
2024-05-08 16:30U:CSTLNews ReleaseLargest Prospective Study to Date Further Supports Performance of DecisionDx(TM)-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
2024-05-03 07:00U:CSTLNews ReleaseDecisionDx(TM)-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
2024-05-02 16:05U:CSTLNews ReleaseCastle Biosciences Reports First Quarter 2024 Results
2024-04-30 16:30U:CSTLNews ReleaseCastle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood's Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
2024-04-11 07:00U:CSTLNews ReleaseCastle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
2024-04-10 17:00U:CSTLNews ReleaseCastle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
2024-04-10 07:00U:CSTLNews ReleaseCastle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
2024-04-04 16:30U:CSTLNews ReleasePresentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx(TM)-Melanoma and DecisionDx(TM)-SCC Tests on the Management of Patients with Skin Cancer
2024-04-02 07:00U:CSTLNews ReleaseCastle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
2024-03-27 17:00U:CSTLNews ReleaseCastle Biosciences Announces Updates to its Board of Directors